183 related articles for article (PubMed ID: 31196778)
21. Comparing methods of long-acting reversible contraception: A qualitative study of Delaware women's perceptions of intrauterine devices and the implant.
Manzer JL; Berndt VK; Bell AV
Contraception; 2022 Sep; 113():73-77. PubMed ID: 35417755
[TBL] [Abstract][Full Text] [Related]
22. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
Modesto W; Bahamondes MV; Bahamondes L
Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
[TBL] [Abstract][Full Text] [Related]
23. Long acting reversible contraception in postpartum adolescents: early initiation of etonogestrel implant is superior to IUDs in the outpatient setting.
Tocce K; Sheeder J; Python J; Teal SB
J Pediatr Adolesc Gynecol; 2012 Feb; 25(1):59-63. PubMed ID: 22051792
[TBL] [Abstract][Full Text] [Related]
24. Canadian Contraception Consensus (Part 2 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
[TBL] [Abstract][Full Text] [Related]
25. A retrospective evaluation of the intrauterine device in a patient population in Buenos Aires, Argentina.
Jagroep SR; Pichardo MS; Arribas L; Heredia G; Coccio E; Palermo TM
J Fam Plann Reprod Health Care; 2016 Apr; 42(2):88-92. PubMed ID: 26420847
[TBL] [Abstract][Full Text] [Related]
26. The impact of menstrual side effects on contraceptive discontinuation: findings from a longitudinal study in Cairo, Egypt.
Tolley E; Loza S; Kafafi L; Cummings S
Int Fam Plan Perspect; 2005 Mar; 31(1):15-23. PubMed ID: 15888405
[TBL] [Abstract][Full Text] [Related]
27. Canadian Contraception Consensus (Part 1 of 4).
Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
[TBL] [Abstract][Full Text] [Related]
28. Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial.
Hofmeyr GJ; Singata-Madliki M; Lawrie TA; Bergel E; Temmerman M
Reprod Health; 2016 Apr; 13():42. PubMed ID: 27091008
[TBL] [Abstract][Full Text] [Related]
29. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
30. Characteristics associated with discontinuation of long-acting reversible contraception within the first 6 months of use.
Grunloh DS; Casner T; Secura GM; Peipert JF; Madden T
Obstet Gynecol; 2013 Dec; 122(6):1214-21. PubMed ID: 24201685
[TBL] [Abstract][Full Text] [Related]
31. Association of Anticipated Insertional Pain With Intrauterine Device Initiation.
Narayan A; Sheeder J; Guiahi M
J Adolesc Health; 2018 Jul; 63(1):37-42. PubMed ID: 30060855
[TBL] [Abstract][Full Text] [Related]
32. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
[TBL] [Abstract][Full Text] [Related]
33. Reasons for contraceptive discontinuation in women 20-39 years old in New Zealand.
Colli E; Tong D; Penhallegon R; Parazzini F
Contraception; 1999 Apr; 59(4):227-31. PubMed ID: 10457866
[TBL] [Abstract][Full Text] [Related]
34. Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder.
Matusiewicz AK; Melbostad HS; Heil SH
Contraception; 2017 Nov; 96(5):365-369. PubMed ID: 28778423
[TBL] [Abstract][Full Text] [Related]
35. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium
Lancet; 2019 Jul; 394(10195):303-313. PubMed ID: 31204114
[TBL] [Abstract][Full Text] [Related]
36. Intrauterine Contraception Continuation in Adolescents and Young Women: A Systematic Review.
Usinger KM; Gola SB; Weis M; Smaldone A
J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):659-667. PubMed ID: 27386754
[TBL] [Abstract][Full Text] [Related]
37. Levels and determinants of switching following intrauterine device discontinuation in 14 developing countries.
Ali MM; Park MH; Ngo TD
Contraception; 2014 Jul; 90(1):47-53. PubMed ID: 24792145
[TBL] [Abstract][Full Text] [Related]
38. An analysis of the personal reasons for discontinuing IUD use.
Petta CA; Amatya R; Farr G; Chi I
Contraception; 1994 Oct; 50(4):339-47. PubMed ID: 7813222
[TBL] [Abstract][Full Text] [Related]
39. Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices.
Woo I; Seifert S; Hendricks D; Jamshidi RM; Burke AE; Fox MC
Contraception; 2015 Dec; 92(6):532-5. PubMed ID: 26408376
[TBL] [Abstract][Full Text] [Related]
40. Frequency of discontinuation of contraceptive use: results from a French population-based cohort.
Moreau C; Bouyer J; Bajos N; Rodríguez G; Trussell J
Hum Reprod; 2009 Jun; 24(6):1387-92. PubMed ID: 19252195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
